REGENXBIO(RGNX) - 2022 Q2 - Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Vit Vasista - Chief Financial Officer Ken Mills - President & Chief Executive Officer Steve Pakola - Chief Medical Officer Conference Call Participants Dane Leone - Raymond James Ellie Merle - UBS Lisa Walter - RBC Capital Markets Andreas Argyrides - Wedbush Securities Mani Foroohar - SVB Securities Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Second Quarter 2022 ...